< Back to companies
DeepCyte
Wilmington, Delaware, United States
DeepCyte is a digital health venture that combines single-cell metabolomics with AI to detect drug toxicity early, predicting and explaining how drugs cause toxicity before they reach patients.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2025
- Website
- www.deepcyte.bio/
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join nowWhat do you think of DeepCyte?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now